ACS	Acute Coronary Syndrome
ACT	Adoptive Cell Therapy
APC	Antigen-Presenting Cell
ATE	Arterial Thromboembolic Event
AVE	Adverse Vascular Event
BMI	Body Mass Index
BNP	Brain Natriuretic Peptide
CAR	Chimeric Antigen Receptor
CI	Cerebral Ischemia
CMR	Cardiac Magnetic Resonance
CR	Complete Remission
CRP	C-Reactive Protein
CTCAE	Common Terminology Criteria for Adverse Events
DC	Dendritic Cell
DVT	Deep Vein Thrombosis
ECG	Electrocardiogram
EPO	Erythropoietin
FDA	Food and Drug Administration
GAL-3	Galectin-3
GLS	Global Longitudinal Strain
GM-CSF	Granulocyte-Macrophage Colony Stimulating Factor
ICI	Immune Checkpoint Inhibitor
ICAM-1	Intracellular Adhesion Molecule-1
IFN-g	Interferon gamma
IL	Interleukin
irAE	Immune-Related Adverse Event
ITAM	Immunoreceptor Tyrosine-based Activation Motif
ITIM	Immunoreceptor Tyrosine-based Inhibition Motif
ITSM	Immunoreceptor Tyrosine-based Switch Motif
LDH	Lactate Dehydrogenase
LDL	Low-Density Lipoprotein
LN	Lymph Node
LV	Left Ventricular
LVEF	Left Ventricular Ejection Fraction
mAb	monoclonal Antibody
MACE	Major Adverse Cardiac Events
MDSC	Myeloid-Derived Suppressor Cell
MI	Myocardial Infarction
MUGA	Multigated Radionuclide Angiography
NF-κB	Nuclear Factor Kappa B
NK	Natural Killer
NLR	Neutrophil-to-Lymphocyte Ratio
NO	Nitric Oxide
OS	Overall Survival
ORR	Overall Response Rate
PE	Pulmonary Embolism
ROS	Reactive Oxygen Species
SDF-1	Stromal cell-derived factor 1 alpha
SNP	Single Nucleotide Polymorphism
TCR	T Cell Receptor
TGF-b	TGF-beta
Th	T helper
TIL	Tumor-Infiltrating Lymphocyte
TME	Tumor Microenvironment
TNF-a	TNF-alpha
Treg	T Regulatory Cell
VCAM-1	Vascular Adhesion Molecule-1
VTE	Venous Thromboembolic Event
VVT	Vesicular Vein Thrombosis